Trade IDEXX Laboratories, Inc. - IDXX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.51 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
IDEXX Laboratories Inc ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 518.62 |
Open* | 518.97 |
1-Year Change* | 23.05% |
Day's Range* | 518.97 - 527.91 |
52 wk Range | 372.50-564.74 |
Average Volume (10 days) | 466.89K |
Average Volume (3 months) | 10.48M |
Market Cap | 39.67B |
P/E Ratio | 48.74 |
Shares Outstanding | 83.05M |
Revenue | 3.59B |
EPS | 9.80 |
Dividend (Yield %) | N/A |
Beta | 1.25 |
Next Earnings Date | Feb 5, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 6, 2023 | 521.39 | 0.07 | 0.01% | 521.32 | 529.29 | 515.97 |
Dec 5, 2023 | 518.62 | 9.81 | 1.93% | 508.81 | 519.32 | 504.87 |
Dec 4, 2023 | 516.36 | 20.66 | 4.17% | 495.70 | 517.06 | 495.70 |
Dec 1, 2023 | 482.24 | 19.34 | 4.18% | 462.90 | 483.55 | 462.22 |
Nov 30, 2023 | 465.69 | 1.27 | 0.27% | 464.42 | 466.24 | 458.11 |
Nov 29, 2023 | 466.29 | -4.05 | -0.86% | 470.34 | 476.25 | 464.54 |
Nov 28, 2023 | 470.24 | -4.18 | -0.88% | 474.42 | 475.46 | 464.24 |
Nov 27, 2023 | 479.17 | 4.62 | 0.97% | 474.55 | 480.35 | 471.57 |
Nov 24, 2023 | 477.56 | 3.24 | 0.68% | 474.32 | 479.62 | 472.97 |
Nov 22, 2023 | 477.88 | -0.41 | -0.09% | 478.29 | 483.18 | 475.02 |
Nov 21, 2023 | 477.57 | 6.30 | 1.34% | 471.27 | 479.75 | 466.57 |
Nov 20, 2023 | 472.77 | 13.30 | 2.89% | 459.47 | 473.58 | 457.37 |
Nov 17, 2023 | 463.45 | -3.15 | -0.68% | 466.60 | 466.87 | 456.13 |
Nov 16, 2023 | 466.53 | 4.81 | 1.04% | 461.72 | 468.78 | 460.66 |
Nov 15, 2023 | 460.45 | 8.19 | 1.81% | 452.26 | 465.91 | 449.10 |
Nov 14, 2023 | 454.13 | 12.77 | 2.89% | 441.36 | 458.61 | 441.36 |
Nov 13, 2023 | 432.14 | 6.49 | 1.52% | 425.65 | 435.92 | 424.47 |
Nov 10, 2023 | 428.61 | 8.01 | 1.90% | 420.60 | 431.72 | 414.86 |
Nov 9, 2023 | 418.53 | -9.43 | -2.20% | 427.96 | 431.83 | 417.25 |
Nov 8, 2023 | 427.58 | 1.54 | 0.36% | 426.04 | 429.67 | 419.94 |
IDEXX Laboratories, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 5, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 IDEXX Laboratories Inc Earnings Release Q4 2023 IDEXX Laboratories Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 3367.32 | 3215.36 | 2706.66 | 2406.91 | 2213.24 |
Revenue | 3367.32 | 3215.36 | 2706.66 | 2406.91 | 2213.24 |
Cost of Revenue, Total | 1362.99 | 1325.93 | 1135.61 | 1041.36 | 971.7 |
Gross Profit | 2004.34 | 1889.43 | 1571.04 | 1365.55 | 1241.54 |
Total Operating Expense | 2468.56 | 2283.33 | 2012.13 | 1854.06 | 1721.91 |
Selling/General/Admin. Expenses, Total | 847.353 | 794.295 | 734.667 | 678.41 | 626.644 |
Research & Development | 254.82 | 161.009 | 141.249 | 133.193 | 117.863 |
Interest Expense (Income) - Net Operating | 3.4 | 2.1 | 0.6 | 1.1 | 3.1 |
Operating Income | 898.765 | 932.028 | 694.524 | 552.846 | 491.335 |
Interest Income (Expense), Net Non-Operating | -38.793 | -29.374 | -32.539 | -30.628 | -33.593 |
Net Income Before Taxes | 859.972 | 902.654 | 661.985 | 522.218 | 457.742 |
Net Income After Taxes | 679.089 | 744.844 | 582.131 | 427.792 | 379.147 |
Minority Interest | 0 | 0.001 | -0.355 | -0.072 | -0.016 |
Net Income Before Extra. Items | 679.089 | 744.845 | 581.776 | 427.72 | 379.131 |
Net Income | 679.089 | 744.845 | 581.776 | 427.72 | 377.031 |
Income Available to Common Excl. Extra. Items | 679.089 | 744.845 | 581.776 | 427.72 | 379.131 |
Income Available to Common Incl. Extra. Items | 679.089 | 744.845 | 581.776 | 427.72 | 377.031 |
Diluted Net Income | 679.089 | 744.845 | 581.776 | 427.72 | 377.031 |
Diluted Weighted Average Shares | 84.6 | 86.572 | 86.722 | 87.542 | 88.47 |
Diluted EPS Excluding Extraordinary Items | 8.02706 | 8.60376 | 6.70852 | 4.88588 | 4.28542 |
Diluted Normalized EPS | 8.02706 | 8.65283 | 6.73388 | 4.88588 | 4.30976 |
Unusual Expense (Income) | 2.6 | ||||
Total Extraordinary Items | -2.1 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 943.63 | 900.195 | 828.568 | 841.661 | 860.546 |
Revenue | 943.63 | 900.195 | 828.568 | 841.661 | 860.546 |
Cost of Revenue, Total | 370.78 | 357.224 | 343.641 | 335.035 | 346.514 |
Gross Profit | 572.85 | 542.971 | 484.927 | 506.626 | 514.032 |
Total Operating Expense | 647.486 | 619.796 | 602.041 | 596.833 | 681.48 |
Selling/General/Admin. Expenses, Total | 230.201 | 217.905 | 214.982 | 213.785 | 211.745 |
Research & Development | 46.505 | 44.667 | 43.418 | 48.013 | 123.221 |
Operating Income | 296.144 | 280.399 | 226.527 | 244.828 | 179.066 |
Interest Income (Expense), Net Non-Operating | -10.215 | -12.711 | -13.312 | -10.645 | -7.983 |
Net Income Before Taxes | 285.929 | 267.688 | 213.215 | 234.183 | 171.083 |
Net Income After Taxes | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Minority Interest | 0 | 0 | 0 | ||
Net Income Before Extra. Items | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Net Income | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Income Available to Common Excl. Extra. Items | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Income Available to Common Incl. Extra. Items | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Diluted Net Income | 224.236 | 214.054 | 172.207 | 180.938 | 131.979 |
Diluted Weighted Average Shares | 83.983 | 83.959 | 83.826 | 84.113 | 84.858 |
Diluted EPS Excluding Extraordinary Items | 2.67002 | 2.54951 | 2.05434 | 2.15113 | 1.55529 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 2.67002 | 2.54951 | 2.05434 | 2.15113 | 1.55529 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 1101.48 | 955.655 | 1062.74 | 679.639 | 654.172 |
Cash and Short Term Investments | 112.546 | 144.454 | 383.928 | 90.326 | 123.794 |
Cash & Equivalents | 112.546 | 144.454 | 383.928 | 90.326 | 123.794 |
Short Term Investments | 0 | ||||
Total Receivables, Net | 490.903 | 425.584 | 374.742 | 307.487 | 272.623 |
Accounts Receivable - Trade, Net | 442.473 | 406.12 | 355.266 | 286.971 | 258.525 |
Total Inventory | 367.823 | 269.03 | 209.873 | 195.019 | 173.303 |
Prepaid Expenses | 41.742 | 41.997 | 34.556 | 31.992 | 30.314 |
Other Current Assets, Total | 88.463 | 74.59 | 59.639 | 54.815 | 54.138 |
Total Assets | 2746.76 | 2437.2 | 2294.56 | 1832.47 | 1537.35 |
Property/Plant/Equipment, Total - Net | 768.092 | 692.768 | 646.338 | 614.452 | 437.27 |
Property/Plant/Equipment, Total - Gross | 1474.01 | 1341.16 | 1233.25 | 1133.48 | 906.003 |
Accumulated Depreciation, Total | -705.914 | -648.391 | -586.914 | -519.03 | -468.733 |
Goodwill, Net | 361.795 | 359.345 | 243.347 | 239.724 | 214.489 |
Intangibles, Net | 97.672 | 99.035 | 52.543 | 58.468 | 41.825 |
Long Term Investments | 55.5 | 18.598 | 12.065 | 13.657 | 10.894 |
Other Long Term Assets, Total | 212.541 | 187.836 | 179.52 | 145.349 | 147.43 |
Total Current Liabilities | 1235.8 | 763.579 | 582.761 | 725.337 | 770.444 |
Accounts Payable | 110.221 | 116.14 | 74.558 | 72.172 | 69.534 |
Accrued Expenses | 385.115 | 416.304 | 372.972 | 288.944 | 233.471 |
Notes Payable/Short Term Debt | 579 | 73.5 | 0 | 288.765 | 398.937 |
Other Current Liabilities, Total | 86.485 | 82.639 | 85.243 | 75.456 | 68.502 |
Total Liabilities | 2138.03 | 1747.21 | 1662.47 | 1655 | 1546.86 |
Total Long Term Debt | 694.387 | 775.205 | 858.492 | 599.488 | 499.571 |
Long Term Debt | 694.387 | 775.205 | 858.492 | 599.488 | 499.571 |
Deferred Income Tax | 8.15 | 8.935 | 11.707 | 33.024 | 29.267 |
Minority Interest | 0 | 0.707 | 0.352 | 0.28 | |
Other Liabilities, Total | 199.688 | 199.492 | 208.806 | 296.801 | 247.3 |
Total Equity | 608.737 | 689.992 | 632.088 | 177.473 | -9.513 |
Common Stock | 15.901 | 16.407 | 15.149 | 15.033 | 15.033 |
Additional Paid-In Capital | 1463.21 | 1377.32 | 1294.85 | 1213.52 | 1138.22 |
Retained Earnings (Accumulated Deficit) | 3599.53 | 2920.44 | 2175.59 | 1595.65 | 1167.93 |
Treasury Stock - Common | -4392.11 | -3570.69 | -2799.89 | -2600.54 | -2288.9 |
Unrealized Gain (Loss) | -0.172 | -0.126 | -0.272 | 0.11 | -0.157 |
Other Equity, Total | -77.624 | -53.358 | -53.343 | -46.292 | -41.634 |
Total Liabilities & Shareholders’ Equity | 2746.76 | 2437.2 | 2294.56 | 1832.47 | 1537.35 |
Total Common Shares Outstanding | 82.894 | 84.562 | 85.449 | 85.471 | 86.099 |
Note Receivable - Long Term | 149.688 | 123.966 | 98.01 | 81.186 | 31.269 |
Current Port. of LT Debt/Capital Leases | 74.982 | 74.996 | 49.988 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1384.23 | 1179.03 | 1149.45 | 1101.48 | 1058.86 |
Cash and Short Term Investments | 331.696 | 132.838 | 111.367 | 112.546 | 99.176 |
Cash & Equivalents | 331.696 | 132.838 | 111.367 | 112.546 | 99.176 |
Total Receivables, Net | 521.865 | 532.287 | 519.861 | 490.903 | 452.897 |
Accounts Receivable - Trade, Net | 503.653 | 511.982 | 492.669 | 442.473 | 430.327 |
Total Inventory | 393.974 | 395.141 | 391.011 | 367.823 | 354.975 |
Prepaid Expenses | 49.875 | 38.918 | 40.084 | 41.742 | 39.696 |
Other Current Assets, Total | 86.82 | 79.841 | 87.123 | 88.463 | 112.115 |
Total Assets | 3086.4 | 2870.81 | 2808.4 | 2746.76 | 2640.07 |
Property/Plant/Equipment, Total - Net | 804.883 | 797.418 | 780.499 | 768.092 | 722.508 |
Goodwill, Net | 361.766 | 364.206 | 362.942 | 361.795 | 355.292 |
Intangibles, Net | 87.129 | 90.932 | 94.361 | 97.672 | 99.968 |
Long Term Investments | 54.333 | 55.391 | 54.271 | 55.5 | 51.76 |
Note Receivable - Long Term | 159.196 | 159.369 | 153.757 | 149.688 | 142.031 |
Other Long Term Assets, Total | 234.867 | 224.465 | 213.122 | 212.541 | 209.649 |
Total Current Liabilities | 970.193 | 883.859 | 1065.63 | 1235.8 | 1189.94 |
Accounts Payable | 112.609 | 107.664 | 117.709 | 110.221 | 110.144 |
Accrued Expenses | 370.053 | 343.016 | 330.763 | 385.115 | 371.286 |
Notes Payable/Short Term Debt | 250 | 264 | 431.5 | 579 | 633 |
Current Port. of LT Debt/Capital Leases | 149.99 | 74.991 | 74.986 | 74.982 | 0 |
Other Current Liabilities, Total | 87.541 | 94.188 | 110.671 | 86.485 | 75.515 |
Total Liabilities | 1789 | 1776.94 | 1967.3 | 2138.03 | 2164.07 |
Total Long Term Debt | 618.813 | 696.844 | 696.362 | 694.387 | 760.814 |
Long Term Debt | 618.813 | 696.844 | 696.362 | 694.387 | 760.814 |
Deferred Income Tax | 10.594 | 5.568 | 5.826 | 8.15 | 14.486 |
Minority Interest | |||||
Other Liabilities, Total | 189.397 | 190.674 | 199.48 | 199.688 | 198.823 |
Total Equity | 1297.41 | 1093.86 | 841.101 | 608.737 | 475.999 |
Common Stock | 16.268 | 16.253 | 15.896 | 15.901 | 15.885 |
Additional Paid-In Capital | 1543.02 | 1515.2 | 1489.9 | 1463.21 | 1437.53 |
Retained Earnings (Accumulated Deficit) | 4250.05 | 4037.82 | 3813.58 | 3599.53 | 3427.32 |
Treasury Stock - Common | -4437.04 | -4401.74 | -4401.67 | -4392.11 | -4323.84 |
Unrealized Gain (Loss) | -0.166 | -0.165 | -0.166 | -0.172 | -0.178 |
Other Equity, Total | -74.725 | -73.5 | -76.449 | -77.624 | -80.716 |
Total Liabilities & Shareholders’ Equity | 3086.4 | 2870.81 | 2808.4 | 2746.76 | 2640.07 |
Total Common Shares Outstanding | 83.068 | 83.06 | 83.004 | 82.894 | 82.995 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 679.089 | 744.844 | 582.131 | 427.792 | 377.047 |
Cash From Operating Activities | 542.984 | 755.546 | 648.063 | 459.158 | 400.084 |
Cash From Operating Activities | 111.9 | 104.596 | 95.998 | 88.011 | 83.178 |
Deferred Taxes | -35.065 | -3.377 | -38.082 | 6.162 | 1.209 |
Non-Cash Items | 60.59 | 47.006 | 39.777 | 42.162 | 30.29 |
Cash Taxes Paid | 239.8 | 161.7 | 110.7 | 88 | 69.7 |
Cash Interest Paid | 39.5 | 30.5 | 32.4 | 29.7 | 34.7 |
Changes in Working Capital | -273.53 | -137.523 | -31.761 | -104.969 | -91.64 |
Cash From Investing Activities | -195.35 | -292.967 | -109.376 | -205.528 | 138.602 |
Capital Expenditures | -158.838 | -119.549 | -107.876 | -155.224 | -122.936 |
Other Investing Cash Flow Items, Total | -36.512 | -173.418 | -1.5 | -50.304 | 261.538 |
Cash From Financing Activities | -370.936 | -697.414 | -248.416 | -286.409 | -597.799 |
Financing Cash Flow Items | -17.472 | -20.702 | -27.304 | -10.582 | -10.641 |
Issuance (Retirement) of Stock, Net | -783.964 | -700.212 | -131.487 | -265.552 | -331.118 |
Issuance (Retirement) of Debt, Net | 430.5 | 23.5 | -89.625 | -10.275 | -256.04 |
Foreign Exchange Effects | -8.606 | -4.639 | 3.331 | -0.689 | -4.768 |
Net Change in Cash | -31.908 | -239.474 | 293.602 | -33.468 | -63.881 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 214.054 | 679.089 | 506.882 | 325.944 | 193.965 |
Cash From Operating Activities | 183.912 | 542.984 | 369.556 | 180.556 | 114.706 |
Cash From Operating Activities | 28.331 | 111.9 | 83.18 | 54.633 | 26.511 |
Deferred Taxes | -3.757 | -35.065 | -36.89 | -23.517 | -5.028 |
Non-Cash Items | 15.893 | 60.59 | 45.981 | 30.447 | 13.5 |
Cash Taxes Paid | 7.2 | 239.8 | 179.72 | 128.325 | 11.4 |
Changes in Working Capital | -70.609 | -273.53 | -229.597 | -206.951 | -114.242 |
Cash From Investing Activities | -39.511 | -195.35 | -146.121 | -96.924 | -41.838 |
Capital Expenditures | -39.511 | -158.838 | -109.609 | -71.924 | -41.838 |
Other Investing Cash Flow Items, Total | -36.512 | -36.512 | -25 | 0 | |
Cash From Financing Activities | -146.081 | -370.936 | -254.216 | -105.387 | -13.48 |
Financing Cash Flow Items | -11.377 | -17.472 | -16.282 | -13.206 | -10.338 |
Issuance (Retirement) of Stock, Net | 12.796 | -783.964 | -722.434 | -554.681 | -254.642 |
Issuance (Retirement) of Debt, Net | -147.5 | 430.5 | 484.5 | 462.5 | 251.5 |
Foreign Exchange Effects | 0.501 | -8.606 | -14.497 | -8.337 | 0.776 |
Net Change in Cash | -1.179 | -31.908 | -45.278 | -30.092 | 60.164 |
Cash Interest Paid | 39.5 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.8895 | 8209522 | 45187 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2072 | 5152755 | 137148 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.5434 | 3771574 | 97303 | 2023-06-30 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 4.3281 | 3592832 | 214529 | 2023-06-30 | LOW |
Fundsmith LLP | Investment Advisor | 3.5676 | 2961551 | 7355 | 2023-06-30 | LOW |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.863 | 2376632 | 20389 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.4249 | 2012999 | 66660 | 2023-06-30 | LOW |
Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.7036 | 1414239 | 7593 | 2023-09-30 | LOW |
William Blair & Company, L.L.C. (Research) | Research Firm | 1.4361 | 1192133 | -17061 | 2023-06-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.4199 | 1178695 | -78372 | 2023-06-30 | LOW |
Brown Advisory | Investment Advisor/Hedge Fund | 1.3987 | 1161124 | 24741 | 2023-09-30 | LOW |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 1.3734 | 1140082 | 13910 | 2023-06-30 | LOW |
Fundsmith Investment Services Ltd. | Investment Advisor | 1.2282 | 1019528 | 15108 | 2023-06-30 | LOW |
Capital World Investors | Investment Advisor | 1.2132 | 1007073 | 8310 | 2023-06-30 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 1.0103 | 838655 | -196239 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9934 | 824629 | 49030 | 2022-12-31 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 0.9692 | 804548 | -82966 | 2023-06-30 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.9465 | 785686 | -11169 | 2023-06-30 | LOW |
Ayers (Jonathan W) | Individual Investor | 0.8937 | 741868 | 147571 | 2023-09-06 | MED |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.8372 | 694960 | 21103 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
IDEXX Labs Company profile
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, IDEXX Laboratories, Inc. revenues increased 19% to $3.22B. Net income increased 28% to $744.8M. Revenues reflect CAG segment increase of 21% to $5.42B, Water segment increase of 14% to $146.5M, United States segment increase of 18% to $2B, Canada segment increase of 30% to $139.7M, Germany segment increase of 23% to $146.8M. Net income benefited from CAG segment income increase of 43% to $824M.
Equity composition
Common Stock $.10 Par, 06/11, 120M auth., 98,835,000 issd., less 42,004,000 shs. in Treas. @ $1.16B. Insiders control approx.1.09%. IPO: 4/92, 1.5M shares @ $20.50 by Lehman Brothers. PO: 10/95, 4.6M shares @ $35 by Cowen & Company. 11/07, 6/95 & 10/93, 2-for-1 stock splits. 06/15, 2-for-1, Stock Split.
Industry: | Veterinary Medical Equipment & Supplies |
One Idexx Drive
WESTBROOK
MAINE 04092-2041
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com